Histological Determination of the Areas Enriched in Cholinergic Terminals and m2 and m3 Muscarinic Receptors in the Mouse Central Auditory System.код для вставкиСкачать
THE ANATOMICAL RECORD 293:1393–1399 (2010) Histological Determination of the Areas Enriched in Cholinergic Terminals and m2 and m3 Muscarinic Receptors in the Mouse Central Auditory System SATOKO HAMADA,1,2 TAKESHI HOUTANI,1 STEFAN TRIFONOV,1 MASAHIKO KASE,1 MASATO MARUYAMA,1 JUN-ICHI SHIMIZU,1,2 TOSHIO YAMASHITA,2 KOICHI TOMODA,2 AND TETSUO SUGIMOTO1* 1 Department of Anatomy and Brain Science, Kansai Medical University, Moriguchi, Osaka, Japan 2 Department of Otolaryngology, Kansai Medical University, Moriguchi, Osaka, Japan ABSTRACT Cholinergic projections to auditory system are vital for coupling arousal with sound processing. Systematic search with in situ hybridization and immunohistochemistry indicated that the ventral nucleus of the medial geniculate body and the nucleus of the brachium of the inferior colliculus constituted cholinergic synaptic sites in the brainstem auditory system, containing a signiﬁcant number of cholinergic axon terminals and m2 receptor-expressing cell bodies. Anat Rec, 293:1393– C 2010 Wiley-Liss, Inc. 1399, 2010. V Key words: central auditory system; muscarinic receptors; vesicular acetylcholine transporter Cholinergic neuronal connections in the central auditory system have been known to play essential roles not only in basic neuromodulatory processes (Habbicht and Vater, 1996; Yigit et al., 2003) but also in behavioral arousal or attention (Metherate and Ashe, 1993; Hsieh et al., 2000), plastic response (Ji et al., 2001, 2005; Ji and Suga, 2008), and cognitive functions. In Alzheimer disease, marked degenerative changes are frequently found throughout major sites of the ascending auditory pathway including the primary auditory cortex, the ventral nucleus of the medial geniculate body, and the central nucleus of the inferior colliculus (Ohm and Braak, 1989; Sinha et al., 1993). At the earlier stages of Alzheimer disease, O’Mahony et al. (1994) found a signiﬁcant dysfunction in the midlatency response, indicating an impairment of the ascending cholinergic system that originates in the pedunculopontine tegmental nucleus and mostly terminates in the thalamus. Buchwald et al. (1991) also observed a close relation between the auditory and ascending cholinergic systems by pharmacological manipulation with a cholinergic agonist and antagonist. Morphologic evaluation of the cholinergic ﬁbers and receptors responsible for the function of the central auditory system has been little accomplished except for the C 2010 WILEY-LISS, INC. V cochlear nucleus, where the distribution density of cholinergic ﬁber–receptor systems has been reported to be regionally variable (Frostholm and Rotter, 1986; Chen et al., 1995; Yao and Godfrey, 1995, 1999; Yao et al., 1996; Jin et al., 2005; Jin and Godfrey, 2006). Tsutsumi et al. (2007) studied the distribution of cholinergic components in the precerebellar nuclei by using vesicular acetylcholine transporter (VAChT) immunohistochemistry and provided evidence that mesopontine cholinergic neurons negatively regulate neocortico-ponto-cerebellar projections at the level of pontine nuclei. Because VAChT is synthesized in major cholinergic neurons and localized Grant sponsors: The Ministry of Education, Culture, Sports, Science and Technology of Japan, The Science Research Promotion Fund of the Japan Private School Promotion Foundation. *Correspondence to: Tetsuo Sugimoto, Department of Anatomy and Brain Science, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan. Fax: þ81-6-6995-2708. E-mail: email@example.com Received 1 September 2009; Accepted 11 March 2010 DOI 10.1002/ar.21186 Published online 17 May 2010 in Wiley InterScience (www. interscience.wiley.com). 1394 HAMADA ET AL. to synaptic vesicles for acetylcholine transport (Erickson et al., 1994; Roghani et al., 1994, 1996; Schafer et al., 1994; Usdin et al., 1995), this molecule is used as a cholinergic marker to delineate terminals and preterminal axons (Schafer et al., 1995, 1998; Gilmor et al., 1996; Weihe et al., 1996; Arvidsson et al., 1997; Ichikawa et al., 1997; Roghani et al., 1998). The aim of this study was to delineate a relative abundance of the ﬁber–receptor system in speciﬁc regions of the central auditory system by means of histochemical detection of cholinergic ﬁbers and receptors. VAChT immunohistochemistry was used to examine cholinergic ﬁbers. Based on the speciﬁc nucleotide sequence for m2 and m3 subtypes, digoxigenin-labeled cRNA probes were designed. With these riboprobes, in situ hybridization was conducted to investigate the distribution of their mRNAs. The regional densities of immunoreactive ﬁbers and hybridization-positive neurons were analyzed in the distribution ﬁeld of the auditory system. Of the ﬁve subtypes of muscarinic receptors (m1–m5), the m2 and m3 subtypes were selected to examine in this study, because these two subtypes have been shown to be abundantly expressed in the cerebral cortex and brainstem regions including some nuclei of the ascending auditory pathway (Buckley et al., 1988; Weiner et al., 1990; Levey et al., 1991, 1994). The m2 and m3 subtypes show different properties in coupling to G-protein and cellular effects (Felder, 1995; Murthy and Makhlouf, 1997; Frazier et al., 2008). The m2 subtypes prefer to be located presynaptic to cholinergic cells and coupled to inhibition of cAMP elevation, whereas m3 subtypes are dominantly located postsynaptic on cholinoceptive cells in forebrain and couple to activation of phosphatidyl inositol turnover. MATERIALS AND METHODS Animals All experiments were performed in compliance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23, revised 1996), and all procedures were approved by the Institutional Animal Care and Use Committee. Tenweek-old male C57BL6/J mice (CLEA Japan, Tokyo, Japan) in which Preyer reﬂex could readily be elicited by hand clap were used in this study. Immunohistochemistry The brain was sliced into 40-lm coronal sections with Cryotome according to Kase et al. (2007). These sections were immunostained for VAChT with essentially the same method as described previously (Tsutsumi et al., 2007). RT-PCR The animals were deeply anesthetized with sodium pentobarbital (100 mg kg1, i.p.). The brain and spinal cord were dissected. Total RNA was extracted from the tissues by the guanidium thiocyanate method. A 10-lg aliquot of the RNA was reverse-transcribed with 5 pmol of oligo(dT)30 as a primer, 1 mM dNTP, and 100 U of ReverTra Ace (Toyobo, Tokyo, Japan) in 20 lL of the reaction mix for 1 hr at 42 C. One microliter aliquot of the RT product was ampliﬁed by PCR. The reaction mixture (20 lL) contained 1 lM forward and reverse primers, 200 lM dNTP, and 0.5 U of Ex Taq Hot Start Version (Takara, Otsu, Japan). The PCR conditions were as follows: pretreatment at 94 C for 2 min; 35 cycles of PCR (denaturation, 0.5 min at 94 C; annealing, 0.5 min at 68 C; and extension, 0.5 min at 72 C). The primers mM2 (forward) 50 -atatcccgggcgagcaagagcagaataaag-30 (30-mer) and mM2 (reverse) 50 -acaggatagccaagattg tcctggtcac-30 (28-mer) were used to amplify the 556-bp fragment, corresponding to the nucleotide 625–1180 from the translation initiation site of mouse m2 muscarinic receptor cDNA (NM_203491; 1401 bp). The primers mM3 (forward) 50 -gtagcagctatgagctacaacagcaagg-30 (28mer) and mM3 (reverse) 50 -cttctggtcttgagagcaaacctcttagcc-30 (30-mer) were used to amplify the 550-bp fragment, corresponding to the nucleotide 866–1415 from the translation initiation site of mouse m3 muscarinic receptor cDNA (NM_033269; 3168 bp). The PCR-ampliﬁed fragments corresponded to the third cytoplasmic loop manifesting a low level of amino acid homology among m1–m5 muscarinic receptors derived from rodent and several other species. These fragments were subcloned into pGEM-T Easy plasmid (Promega, Madison, WI) and sequenced with ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kits (Applied Biosystems, Tokyo, Japan). Riboprobe The constructs were linearized and subjected to in vitro transcription. The reaction was carried out for 2 hr at 37 C in 20 lL of the transcription buffer, pH 8.0, containing 1 lg of template DNA, 10 mM dithiothreitol, 1 mM GTP, 1 mM ATP, 1 mM CTP, 0.65 mM UTP, 0.35 mM digoxigenin-11-UTP (Roche Diagnostics, Mannheim, Germany), 20 U of ribonuclease inhibitor (Toyobo), and 40 U of T7 RNA polymerase (Stratagene, La Jolla, CA). Then, the DNA template was digested with DNase I for 15 min at 37 C. Riboprobes were precipitated with ethanol and LiCl, resuspended in diethylpyrocarbonate (DEPC)-treated distilled water, and adjusted to a concentration of 200 ng lL1. In Situ Hybridization The method followed those developed by Braissant and Wahli (1998) and was modiﬁed as described in detail previously (Trifonov et al., 2009). All solutions used for in situ hybridization were treated with 0.02% DEPC. Mice were perfused with 25 mL of 0.9% saline and 50 mL of a ﬁxative containing 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB; pH 7.4). The brain and spinal cord were saturated with 30% sucrose in 0.1 M PB overnight at 4 C. They were frozen on a sliding microtome and cut into coronal sections of 40-lm thickness. The tissue sections were stored in cryoprotection buffer (30% sucrose, 30% ethylene glycol, and 50 mM PB) at 20 C. Free-ﬂoating sections were rinsed in 0.1% DEPC-activated 0.1 M PB-0.9% saline (PBS, pH 7.4) twice for 15 min. They were equilibrated in 5 standard saline citrate (0.15 M sodium chloride and 0.015 M sodium citrate, pH 7.0; SSC) for 15 min and incubated in hybridization buffer (50% deionized formamide, 40 lg mL1 salmon sperm DNA, 5 SSC) at 55 C for 2 hr. AUDITORY CHOLINERGIC FIBERS AND RECEPTORS 1395 Fig. 1. Differential expression of m2 (a, c) and m3 (b, d) muscarinic receptor mRNA detected by in situ hybridization in mouse brain. (a, b) Levels of thalamus showing hybridization-positive cells in the rostral auditory cortex (*r), lateral habenular nucleus (LHb), and hippocampal CA1–3. The hybridization-positive cells are also seen in wider cortical areas and some regions in the thalamus and hypothalamus. (c, d) Lev- els of superior colliculus (SC) showing hybridization-positive cells in the caudal auditory cortex (*c), SC, parabigeminal nucleus (PBG), pedunculopontine tegmental nucleus (PPTg), and pontine nuclei (Pn). The borders of the rostral and caudal parts of the auditory cortex are indicated by solid triangles. Scale bar ¼ 100 lm. Hybridization was carried out overnight at 55 C. The hybridization mixture contained 1 ng lL1 digoxigenin (Dig)-labeled riboprobe in the hybridization buffer. Hybridized sections were then rinsed with 2 SSC at room temperature for 30 min, with 2 SSC at 65 C for 60 min, and with 0.1 SSC at 65 C twice for 30 min. They were equilibrated with Dig buffer 1 (0.1 M Tris hydrochloride, 0.15 M sodium chloride, pH 7.5) for 5 min. Subsequently, the tissue sections were reacted with alkaline phosphatase-labeled anti-Dig antibody (Roche Diagnostics; diluted 1:5,000) in Dig buffer 1 containing 1% blocking reagent for 2 hr. Sections were rinsed in Dig buffer 1 twice for 15 min. For alkaline phosphatase histochemistry, the tissue sections were equilibrated with Dig buffer 2 (0.1 M Tris hydrochloride, 0.1 M sodium chloride, 0.05 M magnesium chloride, pH 9.5) for 5 min and incubated overnight in a light-protected condition with a reaction mixture containing 450 lg mL1 nitroblue tetrazolium and 175 lg mL1 5-bromo-4-chloro-3-indolylphosphate in Dig buffer 2 at 37 C. The enzyme reaction was terminated by rinsing sections in TE buffer, pH 8.0, for 15 min. Finally, the tissue sections were thoroughly washed in 0.9% saline, mounted onto gelatin-coated glass slides, air dried, equilibrated with 50%, 70%, 95%, 100%, and 100% ethanol, clariﬁed in xylene three times, and coverslipped with Canada balsam. The hybridized sections were examined with Nikon E800M light microscope under brightﬁeld illumination. For the studies of cytoarchitecture, some adjacent sections were stained with 0.1% cresyl violet. The nomenclature of the nuclei and related ﬁber systems and the approximate locations of primary auditory cortex were according to Paxinos and Franklin (2001). Image Analysis Levels of VAChT-immunostained material and digoxigenin labeling were quantiﬁed by digitized image analysis using Image J software ver. 1.39. Gray levels were converted to optical densities by using standard internal 1396 HAMADA ET AL. Fig. 2. Distribution of VAChT-immunoreactive varicose ﬁbers and muscarinic receptor mRNA hybridization-positive cells in mouse brain. (a–c) VAChT-immunoreactive varicose ﬁbers in the medial geniculate nucleus, ventral part (a), nucleus of the brachium of the inferior colliculus (b), and anteroventral cochlear nucleus (c). Expression of m2 (d–h) and m3 (i) muscarinic receptor mRNA in the ventral nucleus of the medial geniculate body (d), nucleus of the brachium of the inferior col- liculus (e), inferior colliculus (f), pontine nuclei (g), facial nucleus (h), and auditory cortex (i). Proﬁles of m2 subtype expression in the pontine nuclei (g) and facial nucleus (h) represent typical labeling of noncholinergic and cholinergic neurons, respectively. CIC, central nucleus of the inferior colliculus; DCIC, dorsal cortex of the inferior colliculus; ECIC, external cortex of the inferior colliculus. Scale bar ¼ 50 lm (a– c), 100 lm (d, e, h, i), and 250 lm (f, g). curves. The background signal was determined by the values obtained from the area of the optic tract and subtracted from values obtained in all brain sites harboring hybridized cells. Three to six subregions were measured per site and the mean optical density determined. Data are expressed as the mean of the values determined from three animals and calculated as signal intensity per unit area. tegmental nucleus is regarded as a robust cholinergic cell group that supplies axons to the thalamus and many brainstem structures (see Tsutsumi et al., 2007 for further refs.). A vast majority of neurons expressing m2 receptors were also present in the pontine nuclei (Figs. 1c, 2g) and in motor nuclei of the cranial nerves, including the facial nucleus (Fig. 2h). The pontine nuclei have been shown to receive abundant VAChT-immunoreactive ﬁbers traveling from the pedunculopontine tegmental nucleus (Tsutsumi et al., 2007). On the other hand, the hybridization-positive neurons preferring m3 subtypes could be seen principally in the cerebral cortex and hippocampus (Fig. 1b,d). In most of the neocortical areas, m3 receptors were localized to cortical layers II and III (Fig. 2i) and, to a lesser degree, to layers V and VI. The m2 receptors were expressed much more weakly in cortical layers IV and V (Fig. 1a,c). In the hippocampus, m3 receptors were present most prominently in CA1-3 RESULTS AND DISCUSSION The tissue sections hybridized with riboprobes for m2 and m3 muscarinic receptor subtypes showed distinct signals with differential expression patterns (Fig. 1). Neurons expressing m2 subtypes were predominantly found in the lateral habenular nucleus, superior colliculus, parabigeminal nucleus, and pedunculopontine tegmental nucleus (Fig. 1a,c). The pedunculopontine AUDITORY CHOLINERGIC FIBERS AND RECEPTORS 1397 rior colliculus, nucleus of the brachium of the inferior colliculus, ventral nucleus of the medial geniculate body, and primary auditory cortex (Fig. 2d–f,i). These sites were subjected to densitometric analysis (Fig. 3) because considerable amounts of VAChT-immunoreactive varicose ﬁbers and terminal-like structures were detectable in some of these sites (Fig. 2a–c). VAChT-Immunoreactive Varicose Fibers The densest accumulation of VAChT-immunoreactive varicose ﬁbers was seen in the cochlear nuclei, especially on the margin of the anteroventral cochlear nucleus (Fig. 2c). In the anteroventral cochlear nucleus and in the posteroventral cochlear nucleus, however, a vast majority of the nuclear territories were virtually free from such varicose ﬁbers (Fig. 3a). Thus, the VAChT immunoreactivity in the entire cochlear nucleus was presumed to be less intense than that indicated by densitometry in the cochlear nuclear areas containing the densest accumulation of VAChT-immunoreactive ﬁbers. Immunolabeled ﬁbers and terminal-like structures were present at moderate levels in the primary auditory cortex, the ventral nucleus of the medial geniculate body (Fig. 2a), and the nucleus of the brachium of the inferior colliculus (Fig. 2b). VAChT-immunoreactive varicose ﬁbers were seen at low levels in the remaining sites. m2 Hybridization-Positive Cells The highest density of distribution of neurons expressing m2 subtypes was observed in the dorsal cochlear nucleus in accordance with earlier observations in the cochlear nucleus (Yao et al., 1996; Jin and Godfrey, 2006) (Fig. 3b). The distribution density of cells with m2 hybridization signal was moderate in the primary auditory cortex, the ventral nucleus of the medial geniculate body (Fig. 2d), the nucleus of the brachium of the inferior colliculus (Fig. 2e), and the dorsal and external cortex of the inferior colliculus (Fig. 2f). In the remaining sites, the distribution density of neurons expressing m2 subtype was low. Fig. 3. Density of signals representative of VAChT-immunoreactive varicose ﬁbers (a) and neurons expressing m2 (b) and m3 (c) mRNA in nine regions of mouse central auditory system. The cortex (Cx) in which measurements were done denotes the primary auditory cortex. In each brain region, signal density was measured at ﬁve subregions and averaged. (a) The highest density of VAChT-immunoreactive varicose ﬁbers was obtained in the anteroventral cochlear nucleus (AVCN) followed by the Cx, posteroventral cochlear nucleus (PVCN), and nucleus of the brachium of the inferior colliculus (BIC). (b) The highest density of m2 hybridization-positive cells was detected in the dorsal cochlear nucleus (DCN) followed by the Cx, dorsal cortex of the inferior colliculus (DCIC), BIC, ventral nucleus of the medial geniculate body (MGV), and external cortex of the inferior colliculus (ECIC). (c) The Cx especially showed a dense accumulation of m3 hybridizationpositive cells. All the other regions measured had a very low level of the density. (Fig. 1b), whereas m2 receptors were marked in the dentate gyrus (Fig. 1a). The m2 and m3 subtypes were expressed in the central auditory system including the cochlear nuclei, infe- m3 Hybridization-Positive Cells Many neurons expressing m3 muscarinic receptor mRNA were seen in the primary auditory cortex and mainly localized to the layers II and III (Fig. 2i). The neurons expressing m3 receptors were only seen at low levels in all the other sites of the central auditory system (Fig. 3c). In view of the fact that the density of distribution of cholinergic terminal-like structures and neurons with m2 hybridization signal was moderate in layers IV and V of the primary auditory cortex, the ventral nucleus of the medial geniculate body, and the nucleus of brachium of the inferior colliculus, it was assumed that the signaling in these regions might be implemented by m2-mediated cholinergic transmission. In the inferior colliculus and the dorsal cochlear nucleus, the distribution density of cells with m2 hybridization signal was moderate and cholinergic axon terminals were small in number. Thus, it was supposed that the m2-mediated signaling in these regions might not be dominant. 1398 HAMADA ET AL. The nucleus of the brachium of the inferior colliculus contains auditory neurons subserving the coding for auditory space in association with neurons located in the deep layers of the superior colliculus (Kudo et al., 1984; Schnupp and King, 1997; King et al., 1998; Doubell et al., 2000; Nodal et al, 2005). Nevertheless, the chemical architecture of the nucleus of the brachium of the inferior colliculus has been little elucidated. Our ﬁndings revealed the relative abundance of m2-receptor subtype and cholinergic terminal-like elements in the nucleus of the brachium of the inferior colliculus (Fig. 2e) and m2 subtype-expressing neurons in the deep layer of superior colliculus (Fig. 1c), thus implicating an important contribution of m2 muscarinic receptors for the coding of auditory space information. The cerebral cortex and thalamus have been shown to express multiple types of muscarinic receptors including m2 and m3 subtypes (Buckley et al., 1988; Levey et al., 1991, 1994). Our results suggest that the m3 muscarinic receptor is the predominant subtype in the cortex, expressed in the neurons of the superﬁcial cortical layers. Neurons of the auditory cortex and medial geniculate nucleus are vulnerable to neurodegeneration characteristic to Alzheimer disease (Sinha et al., 1993). Important question is whether the neurons expressing m3 subtypes might be one of the most vulnerable types. In normal cortices, stimulation of the neurons of the nucleus basalis facilitates auditory thalamocortical synaptic transmission (Metherate and Ashe, 1993; Hsieh et al., 2000). Activation of m3 receptors in the superﬁcial layers of the cerebral cortex might be involved in the process of the synaptic transmission in the auditory thalamocortical system. ACKNOWLEDGMENTS The authors thank Fumio Yamashita and Tetsuji Yamamoto for technical assistance and Yuki Okada for expert secretarial work. Stefan Trifonov is supported by the Japanese Government Monbukagakusho (MEXT) Scholarship Program. LITERATURE CITED Arvidsson U, Riedl M, Elde R, Meister B. 1997. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 378:454–467. Braissant O, Wahli W. 1998. A simpliﬁed in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica 1:10–16. Buchwald JS, Rubinstein EH, Schwafel J, Strandburg RJ. 1991. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist. Electroencephalogr Clin Neurophysiol 80:303–309. Buckley NJ, Bonner TI, Brann MR. 1988. Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci 8:4646–4652. Chen K, Waller HJ, Godfrey DA. 1995. Muscarinic receptor subtypes in rat dorsal cochlear nucleus. Hear Res 89:137–145. Doubell TP, Baron J, Skaliora I, King AJ. 2000. Topographical projection from the superior colliculus to the nucleus of the brachium of the inferior colliculus in the ferret: convergence of visual and auditory information. Eur J Neurosci 12:4290–4308. Erickson JD, Varoqui H, Schafer MK, Modi W, Diebler MF, Weihe E, Rand J, Eiden LE, Bonner TI, Usdin TB. 1994. Functional identiﬁcation of a vesicular acetylcholine transporter and its expression from a ‘‘cholinergic’’ gene locus. J Biol Chem 269: 21929–21932. Felder CC. 1995. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9:619–625. Frazier EP, Peters SL, Braverman AS, Ruggieri MR, Sr., Michel MC. 2008. Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and betaadrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 377: 449–462. Frostholm A, Rotter A. 1986. Autoradiographic localization of receptors in the cochlear nucleus of the mouse. Brain Res Bull 16: 189–203. Gilmor ML, Nash NR, Roghani A, Edwards RH, Yi H, Hersch SM, Levey AI. 1996. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 16:2179–2190. Habbicht H, Vater M. 1996. A microiontophoretic study of acetylcholine effects in the inferior colliculus of horseshoe bats: implications for a modulatory role. Brain Res 724:169–179. Hsieh CY, Cruikshank SJ, Metherate R. 2000. Differential modulation of auditory thalamocortical and intracortical synaptic transmission by cholinergic agonist. Brain Res 880:51–64. Ichikawa T, Ajiki K, Matsuura J, Misawa H. 1997. Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry. J Chem Neuroanat 13:23–39. Ji W, Gao E, Suga N. 2001. Effects of acetylcholine and atropine on plasticity of central auditory neurons caused by conditioning in bats. J Neurophysiol 86:211–225. Ji W, Suga N. 2008. Tone-speciﬁc and nonspeciﬁc plasticity of the auditory cortex elicited by pseudoconditioning: role of acetylcholine receptors and the somatosensory cortex. J Neurophysiol 100:1384–1396. Ji W, Suga N, Gao E. 2005. Effects of agonists and antagonists of NMDA and ACh receptors on plasticity of bat auditory system elicited by fear conditioning. J Neurophysiol 94:1199–1211. Jin YM, Godfrey DA. 2006. Effects of cochlear ablation on muscarinic acetylcholine receptor binding in the rat cochlear nucleus. J Neurosci Res 83:157–166. Jin YM, Godfrey DA, Sun Y. 2005. Effects of cochlear ablation on choline acetyltransferase activity in the rat cochlear nucleus and superior olive. J Neurosci Res 81:91–101. Kase M, Houtani T, Sakuma S, Tsutsumi T, Sugimoto T. 2007. Laser microdissection combined with immunohistochemistry on serial thin tissue sections: a method allowing efﬁcient mRNA analysis. Histochem Cell Biol 127:215–219. King AJ, Jiang ZD, Moore DR. 1998. Auditory brainstem projections to the ferret superior colliculus: anatomical contribution to the neural coding of sound azimuth. J Comp Neurol 390:342–365. Kudo M, Tashiro T, Higo S, Matsuyama T, Kawamura S. 1984. Ascending projections from the nucleus of the brachium of the inferior colliculus in the cat. Exp Brain Res 54:203–211. Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA. 1994. Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience 63:207–221. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. 1991. Identiﬁcation and localization of muscarinic acetylcholine receptor proteins in brain with subtype-speciﬁc antibodies. J Neurosci 11:3218–3226. Metherate R, Ashe JH. 1993. Nucleus basalis stimulation facilitates thalamocortical synaptic transmission in the rat auditory cortex. Synapse 14:132–143. Murthy KS, Makhlouf GM. 1997. Differential coupling of muscarinic m2 and m3 receptors to adenylyl cyclases V/VI in smooth muscle. Concurrent m2-mediated inhibition via Galphai3 and m3-mediated stimulation via Gbetagammaq. J Biol Chem 272: 21317–21324. Nodal FR, Doubell TP, Jiang ZD, Thompson ID, King AJ. 2005. Development of the projection from the nucleus of the brachium of the inferior colliculus to the superior colliculus in the ferret. J Comp Neurol 485:202–217. AUDITORY CHOLINERGIC FIBERS AND RECEPTORS Ohm TG, Braak H. 1989. Auditory brainstem nuclei in Alzheimer’s disease. Neurosci Lett 96:60–63. O’Mahony D, Rowan M, Feely J, Walsh JB, Coakley D. 1994. Primary auditory pathway and reticular activating system dysfunction in Alzheimer’s disease. Neurology 44:2089–2094. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press. Roghani A, Feldman J, Kohan SA, Shirzadi A, Gundersen CB, Brecha N, Edwards RH. 1994. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc Natl Acad Sci USA 91:10620–10624. Roghani A, Shirzadi A, Butcher LL, Edwards RH. 1998. Distribution of the vesicular transporter for acetylcholine in the rat central nervous system. Neuroscience 82:1195–1212. Roghani A, Shirzadi A, Kohan SA, Edwards RH, Butcher LL. 1996. Differential distribution of the putative vesicular transporter for acetylcholine in the rat central nervous system. Brain Res Mol Brain Res 43:65–76. Schafer MK, Eiden LE, Weihe E. 1998. Cholinergic neurons and terminal ﬁelds revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience 84:331–359. Schafer MK, Weihe E, Erickson JD, Eiden LE. 1995. Human and monkey cholinergic neurons visualized in parafﬁn-embedded tissues by immunoreactivity for VAChT, the vesicular acetylcholine transporter. J Mol Neurosci 6:225–235. Schafer MK, Weihe E, Varoqui H, Eiden LE, Erickson JD. 1994. Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat. J Mol Neurosci 5:1–26. Schnupp JW, King AJ. 1997. Coding for auditory space in the nucleus of the brachium of the inferior colliculus in the ferret. J Neurophysiol 78:2717–2731. 1399 Sinha UK, Hollen KM, Rodriguez R, Miller CA. 1993. Auditory system degeneration in Alzheimer’s disease. Neurology 43: 779–785. Trifonov S, Houtani T, Hamada S, Kase M, Maruyama M, Sugimoto T. 2009. In situ hybridization study of the distribution of choline acetyltransferase mRNA and its splice variants in the mouse brain and spinal cord. Neuroscience 159:344–357. Tsutsumi T, Houtani T, Toida K, Kase M, Yamashita T, Ishimura K, Sugimoto T. 2007. Vesicular acetylcholine transporter-immunoreactive axon terminals enriched in the pontine nuclei of the mouse. Neuroscience 146:1869–1878. Usdin TB, Eiden LE, Bonner TI, Erickson JD. 1995. Molecular biology of the vesicular ACh transporter. Trends Neurosci 18: 218–224. Weihe E, Tao-Cheng JH, Schafer MK, Erickson JD, Eiden LE. 1996. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a speciﬁc population of small synaptic vesicles. Proc Natl Acad Sci USA 93: 3547–3552. Weiner DM, Levey AI, Brann MR. 1990. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050–7054. Yao W, Godfrey DA. 1995. Immunohistochemistry of muscarinic acetylcholine receptors in rat cochlear nucleus. Hear Res 89:76–85. Yao W, Godfrey DA. 1999. Vesicular acetylcholine transporter in the rat cochlear nucleus: an immunohistochemical study. J Histochem Cytochem 47:83–90. Yao W, Godfrey DA, Levey AI. 1996. Immunolocalization of muscarinic acetylcholine subtype 2 receptors in rat cochlear nucleus. J Comp Neurol 373:27–40. Yigit M, Keipert C, Backus KH. 2003. Muscarinic acetylcholine receptors potentiate the GABAergic transmission in the developing rat inferior colliculus. Neuropharmacology 45:504–513.